You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美国FDA顾问小组建议批准使用辉瑞疫苗 据报或数日内公布紧急授权
阿思达克 12-11 11:19
美国食品及药物管理局(FDA)的顾问小组周四(10日)以17票赞成、4票反对及1票弃权,投票通过建议批准紧急使用辉瑞(PFE.US)及BioNTech(BNTX.US)研发的新型肺炎疫苗,小组认为该疫苗的好处,大过已知风险,而FDA多数遵循其顾问小组的建议。

《纽约时报》引述相关人士报道,预计FDA将在周六(12日)授予该疫苗紧急使用授权,《彭博》则称授权有可能在数日内公布。

美国政府预计,一旦FDA公布授权,将有290万剂疫苗可立即提供给各州。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account